Bioimpedance Measurement of Abdominal Free Flaps During Arterial and Venous Weaning in Breast Reconstruction
MONITRANS2
1 other identifier
interventional
10
1 country
1
Brief Summary
As the occurrence of thrombosis in post surgery is rare, it seemed difficult to study only this one. This is why we decided to test the bioimpedance, temperature and green, red and infrared light absorption measurements of the prototype during the weaning of the flap during surgery. Indeed, during weaning the investigators voluntarily interrupt the arterial and venous flow to transfer the flap to the breast. This weaning corresponds to a thrombosis model. The patients will benefit from an "improved" postoperative monitoring. Indeed, in addition to the classical clinical monitoring, they will benefit from an additional monitoring during 5 days thanks to the realization of an ultrasound of the flap which will be carried out every 6 hours the first 24 hours then every 12 hours. This protocol is therefore a feasibility study for the collection of data of interest.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 8, 2022
CompletedStudy Start
First participant enrolled
December 8, 2022
CompletedFirst Posted
Study publicly available on registry
February 2, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedFebruary 2, 2023
December 1, 2022
12 months
December 8, 2022
January 24, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Measurement of impedence
Impedence measurement during episode of ischemia.
one day
Interventions
The device will be installed during the patient's operation. It will be attached to the healthy skin of the flap (without wound or scar) by sterile glue. It will then be covered with a self-adhesive "tegaderm" type dressing. The wound will be isolated from the device with a hermetic silicone dressing of the "Mepilex" type, for example. There will therefore be no communication between the measuring device and the surgical wound.
Eligibility Criteria
You may qualify if:
- Woman undergoing microsurgical breast reconstruction using a free abdominal flap
- Age greater than or equal to 18 years
You may not qualify if:
- Pregnant patient
- Patient with an active implantable device such as a pacemaker or an artificial heart
- Patient refusing to participate in the study
- Age less than 18 years old
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Amiens
Amiens, 80054, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 8, 2022
First Posted
February 2, 2023
Study Start
December 8, 2022
Primary Completion
December 1, 2023
Study Completion
December 1, 2023
Last Updated
February 2, 2023
Record last verified: 2022-12
Data Sharing
- IPD Sharing
- Will not share